Enanta Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $5.70 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.73 | $1.29 B | -7.16 | 85 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $51.08 | $3.53 B | -11.86 | 290 | $4.01 M |
 DSGN
|
Design Therapeutics, Inc. | $5.39 | $217.51 M | -3.7 | 57 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.69 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.29 | $243.38 M | -1.59 | 129 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.12 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 INBX
|
Inhibrx Biosciences, Inc. | $15.65 | $241.02 M | -1.44 | 166 | $1.80 M |
 IPSC
|
Century Therapeutics, Inc. | $1.71 | $244.54 M | -1.32 | 152 | $2.24 M |
 KRON
|
Kronos Bio, Inc. | $1.00 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYEL
|
Lyell Immunopharma, Inc. | $1.38 | $619.50 M | -2.7 | 224 | $130,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.09 | $652.38 M | -6.03 | 28 | $0 |
 MRUS
|
Merus N.V. | $49.96 | $3.50 B | -19.38 | 172 | $43.95 M |
 RVMD
|
Revolution Medicines, Inc. | $45.34 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.29 | $774.50 M | -6.14 | 110 | $8.78 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |